Generic drug cost containment in Medicaid: lessons from five State MAC programs

Health Care Financing Review, Spring, 2004 by Richard G. Abramson, Catherine A. Harrington, Raad Missmar, Susan P. Li, Daniel N. Mendelson

Richard G. Abramson, Raad Missmar, Susan P. Li, and Daniel N. Mendelsen are with The Health Strategies Consultancy LLC. Catherine A. Harrington is with Nova Southeastern University College of Pharmacy. The research in this article was funded by the Centers for Medicare & Medicaid Services (CMS) under Task Order Number GS-23F-9785H to American Management Systems, Inc., and The Health Strategies Consultancy LLC.

The views expressed in this article are those of the authors and do not necessarily reflect the views of American Management Systems, Inc., The Health Strategies Consultancy LLC, Nova Southeastern University College of Pharmacy, or CMS.